Heterogeneous SPP1-expressing esophageal cancer cells license immunotherapy resistance by organizing an immunosuppressive niche
Jiakang Ma, Jianlin Zhu, Yiling Chen, Xiaodong Chu, Jie Zeng, Hongyu Chen, Yuhao Liu, Xiaosheng Lin, Lei Zhang, Jinyuan Yi, Guangping Zhang, Songwang Cai, Yusheng Lin, Lu Wang · 2026
Read Heterogeneous SPP1-expressing esophageal cancer cells license immunotherapy resistance by organizing an immunosuppressive niche by Jiakang Ma, Jianlin Zhu, Yiling Chen, Xiaodong Chu, Jie Zeng, Hongyu Chen, Yuhao Liu, Xiaosheng Lin, Lei Zhang, Jinyuan Yi, Guangping Zhang, Songwang Cai, Yusheng Lin, Lu Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13325454.txt.
Description
Jiakang Ma and co-authors find a tumor cell group that shields esophageal cancer from immunotherapy in a 2026 study. More than half of patients fail to gain a major response from chemo plus checkpoint drugs.
Multi-omics work spotted cancer cells rich in SPP1, apart from the known SPP1 source in macrophages. These cells raised PD-L1 through mTORC1 and STAT3, tired out killer T cells through CD44 signaling, and bent macrophages toward a suppressive state. Spatial maps showed the cells organizing sheltered niches inside tumors. Blocking SPP1 teamed well with anti-PD-1 therapy in models. Drug screens also flagged microtubule and kinase blockers as weapons against these cells.
Catalog record
| CREATOR | Jiakang Ma, Jianlin Zhu, Yiling Chen, Xiaodong Chu, Jie Zeng, Hongyu Chen, Yuhao Liu, Xiaosheng Lin, Lei Zhang, Jinyuan Yi, Guangping Zhang, Songwang Cai, Yusheng Lin, Lu Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 68769 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |